Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06472206 · ClinicalTrials.gov registry record · NA
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
A NA study of HIV/AIDS, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 420
- Enrollment target
- 5
- Study locations
NCT06472206: Recruiting NA study of HIV/AIDS, sponsored by Columbia University.
NCT06472206 is a NA study of HIV/AIDS that is actively recruiting participants, run by Columbia University. The registered enrollment target is 420 participants, below the 33,174-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06472206, a NA study of HIV/AIDS, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
- 5
- Study locations
Study Summary
Although global efforts have been made to end the HIV epidemic, there are still some gaps in HIV testing, antiretroviral therapy (ART) adherence, and viral suppression (VS) among people with HIV (PWH). These gaps are particularly prominent in the Deep South of the United States (US), where PWH face challenges in accessing healthcare services. In response, a team of experienced researchers has developed and tested the Community Health Workers And MHealth to ImProve Viral Suppression (CHAMPS) intervention. This intervention uses mobile health (mHealth) technology and a team of community health workers (CHW) to design an intervention to improve ART adherence and VS. The CHAMPS+ intervention adds a CHW delivered supportive risk reduction counseling during periods of non-suppression to prevent HIV transmission. The study will engage the participants by developing culturally relevant materials and retention strategies, evaluating the clinical effectiveness and sustainability of the intervention in Deep South settings, and assessing regionalized implementation factors. Ultimately, the study will test the effectiveness of CHAMPS+ on ART adherence and viral load suppression for PWH in Alabama, Louisiana, and Mississippi.
Primary Outcome
Using blood samples obtained during standard of care visits, viral load levels will be used to asses ART adherence.
Conditions Studied
Interventions
- DEVICE CleverCap
- BEHAVIORAL CHW Sessions
Study Locations (5)
Alabama
- Health Services Center, Inc. - Hobson City
- Unity Wellness Center - Opelika
Louisiana
- Louisiana State University Health Sciences Center in New Orleans - New Orleans
- Tulane University - New Orleans
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2024-09-23 |
| Est. Completion | 2027-12-22 |
| Phase | NA |
What NCT06472206 shows while recruiting
NCT06472206 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 33,174-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower).
The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which CleverCap is the first listed.
NCT06472206 lists 5 locations in 3 states (Alabama, Louisiana, Mississippi).
Frequently Asked Questions
What is clinical trial NCT06472206 about?
NCT06472206 is a clinical study titled "Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)". Although global efforts have been made to end the HIV epidemic, there are still some gaps in HIV testing, antiretroviral therapy (ART) adherence, and viral suppression (VS) among people with HIV (PWH). These gaps are particularly prominent in the Deep South of the United States (US), where PWH face ...
What is the current status of trial NCT06472206?
This trial is currently recruiting. It is a NA study. The enrollment target is 420 participants. The study started on 2024-09-23. Estimated completion is 2027-12-22.
What conditions does trial NCT06472206 study?
This clinical trial studies the following conditions: HIV/AIDS.
What interventions are being tested in trial NCT06472206?
The interventions under investigation include: CleverCap (DEVICE), CHW Sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06472206?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06472206 being conducted?
This trial has 5 study locations across Alabama, Louisiana, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06472206's enrollment target sits among peer trials
420 13th of 61 higher than 49 of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI